Denis Chem Lab Ltd
DENISCHEMBSE
₹62.58▲ +0.58 (+0.94%)
Whole company worth₹87 Cr
Price for ₹1 of profit₹10
1-year range₹56 – ₹92
The short version
A steadily growing, thinly profitable business — priced low for what it earns.
Everything below is worked out from Denis Chem Lab's own filed results and the exchange's data, and written so you do not need to know any finance terms. Where a term matters, we say what it means.
01What does it do?
Denis Chem Lab is a micro-sized company in pharmaceuticals.
Incorporated in 1982, Denis Chem Lab Ltd does manufacturing of Pharmaceuticals Transfusion Solution in Bottles
- Whole company is worth
- ₹87 crore
- Run by
- Nirmal Himanshu Patel
- Shareholders
- 7,201 people
- Listed since
- 2014
A very small company by stock-market value — prices can swing hard and trading can be thin.
02Is it growing?
Sales have grown 11% a year for 5 years.
At that pace a business doubles in size roughly every 7 years. Profit grew even faster, at 33% a year — the business is keeping more of each rupee it brings in.
Point at a bar for exact figures · amounts in ₹ crore
03Does it make money?
Out of every ₹100 it sells, it keeps ₹4.6 as profit.
Here is where the money from Denis Chem Lab's sales went in FY26, the latest full year it has reported.
₹54
₹35
- ₹54Making or buying what it sellsraw materials, stock, goods bought for resale
- ₹35Running the businessstaff, rent, marketing, power and everything else
- ₹0.5Interest on its loansthe cost of borrowed money
- ₹3.8Wear and tearmachines, stores and buildings losing value over time
- ₹1.9Taxincome tax paid to the government
- ₹4.6Profit it keepswhat is left for the company's owners
On the money its owners have put in
It earns ₹9 a year on every ₹100 its owners have invested.
Bank FD ~₹6–7
₹9
₹0₹10₹20₹30₹40
That figure is called return on equity (ROE). Under ₹12 is a thin return for the risk of owning shares. For comparison, a bank fixed deposit pays roughly ₹6–7.
Does the profit turn into cash?
For every ₹100 of profit it reported, ₹122 actually came in as cash.
Profit it reported₹28 Cr
Cash its business brought in₹34 Cr
Over the last 3 years: ₹28 crore of profit and ₹34 crore of cash from its day-to-day business. Profit that shows up as cash is the most believable kind.
04Is the price high or low?
You pay ₹10 for every ₹1 of profit it makes in a year.
This is the P/E ratio: share price divided by a year's profit per share. A P/E of 10 means buyers are paying for about 10 years of today's profit up front.
The share price over the past year
It is 32% below its highest price of the past year and 12% above its lowest.
05Who owns it?
Its founders and parent group own 39 of every 100 shares — a large stake, though not a majority.
If the company were split into 100 equal shares, this is who would hold them. 7,201 people and institutions hold its shares.
As filed for the quarter ending 30 Sept 2026. Arrows show the change since the quarter before, in percentage points.
06What is going well, and what to watch
Two things going well, one thing worth watching.
Picked out of the numbers above by fixed rules — the same rules for every company — so nothing here is somebody's opinion.
Going well
- Has almost no debt — it is not at the mercy of lenders.
- Pays a dividend of about 3.5% of its share price each year.
Worth watching
- Thinly traded — only about ₹5 lakh of shares change hands a day, so buying or selling can move the price.
07What happened lately?
Latest quarter: sales up 2%, profit down 17%.
Apr–Jun 2026 is the most recent quarter it has reported. Each figure is compared with the same three months a year earlier, because many businesses sell more in some seasons than others.
Sales
₹44 Cr
▲ 1.7% on a year earlier
Profit
₹2.0 Cr
▼ 17.3% on a year earlier
No notable developments in the last few weeks.
Advanced view
Every number, every table, the full chart.
Ten years of statements, quarterly results, peers side by side, technical indicators, analyst estimates, bulk deals and filings.
Ask DoXy
Still have a question about Denis Chem Lab?
This page describes Denis Chem Lab using its reported figures and exchange data. It is for information only and is not investment advice or a recommendation to buy, sell or hold. DocStoX is not a SEBI-registered investment adviser or research analyst.
Denis Chem Lab Ltd (DENISCHEM): company summary
Annual revenue rose 4.9% to ₹182 crore, while annual net profit remained flat at ₹8 crore.
Denis Chem Lab Ltd (DENISCHEM) is a micro-cap Healthcare company valued at ₹87 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Denis Chem Lab Ltd last traded at ₹62.58, modestly up 0.94% on the day.
- Financial performance
- Annual revenue rose 4.9% to ₹182 crore, while annual net profit remained flat at ₹8 crore. The latest quarter saw revenue rise 1.7% to ₹44 crore, but net profit fell 17.3% to ₹2 crore compared to the same quarter a year earlier.
- Valuation multiples
- The stock trades at 10.3 times earnings, a discount to the Healthcare median of 32.0, 1.09 times book value. It yields 3.5%.
- Things to watch
- Net profit margin declined 0.0 percentage points to 4.6%. The stock is 32.6% below its 52-week high. Net profit fell 17.3% in the latest quarter.
- Where it stands
- Denis Chem Lab Ltd reported flat annual net profit and a slight rise in revenue. The latest quarter showed a drop in net profit despite a small increase in revenue. The stock is trading 32.6% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
More Healthcare stocks · Pharmaceuticals
Explore Denis Chem Lab Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Denis Chem Lab Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Denis Chem Lab Ltd with peers
Denis Chem Lab Ltd vs Sun Pharmaceutical Industries LimitedDenis Chem Lab Ltd vs Divi's Laboratories LimitedDenis Chem Lab Ltd vs Torrent Pharmaceuticals LimitedDenis Chem Lab Ltd vs Laurus Labs LimitedDenis Chem Lab Ltd vs Zydus Lifesciences LimitedDenis Chem Lab Ltd vs Apollo Hospitals Enterprise Limited
Related tools & concepts
Value Denis Chem Lab Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing